Zoledronic Acid - Api
Sorafenib, is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer,FLT3-ITDpositive AML and radioactive iodine resistant advanced thyroid carcinoma.
Pharmacopoeia: IP/IH
Molar mass: 464.825 g/mol
CAS ID: 284461-73-0
Formula: C21H16ClF3N4O3
ChemSpider ID: 187440